| 2,5-Diazabicyclo[2.2.2]octane, 2-[6-[2-methoxy-5-(trifluoromethyl)phenyl]thieno[2,3-d]pyrimidin-4-yl]- |
化合物 KRAS G12D INHIBITOR 14 |
2765254-39-3 |
| Tucotuzumab Celmoleukin |
Tucotuzumab Celmoleukin |
339986-90-2 |
| Murlentamab |
Murlentamab |
2058047-65-5 |
| Avizakimab |
艾维奇单抗 |
2229685-51-0 |
| ETHYL 5-CHLORO-3-(METHYLTHIO)-1,2,4-TRIAZINE-6-CARBOXYLATE |
3-甲硫基-5-氯-6-甲酸乙酯-1,2,4-三嗪 |
75824-03-2 |
| 4-Amino-2-(methylthio)pyrimidine-5-carbaldehyde |
4-氨基-2-甲巯基嘧啶-5-甲醛 |
770-31-0 |
| 4-PYRIDIN-4-YL-BUTAN-1-OL |
4-吡啶丁醇 |
5264-15-3 |
| 1-[2-(4-CHLOROPHENYL)-1-(1-HYDROXY-1-PHENYLETHYL)ETHYL]-1,2,4-TRIAZOLE |
3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇 |
224047-41-0 |
| PF-01247324 |
2 - 吡啶甲酰胺,6 - 氨基-N-甲基-5 - (2,3,5 - 三氯苯基) - |
875051-72-2 |
| AEEA-AEEA |
17-氨基-10-氧代-3,6,12,15-四氧杂-9-氮杂十七烷酸 |
1143516-05-5 |
| 1-Ethyl (2R,4S)-4-[[[3,5-bis(trifluoromethyl)phenyl]methyl][5-(3-carboxypropoxy)-2-pyrimidinyl]amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylate |
(2R,4S)-4-[[[3,5-双(三氟甲基)苯基]甲基][5-(3-羧丙氧基)-2-嘧啶基]氨基]-2-乙基-3,4-二氢-6-(三氟甲基)-1(2H)-喹啉羧酸乙酯 |
866399-87-3 |
| LYN-1604 |
蓝木定制的新产品 |
2088939-99-3 |
| (R)-N-(2-(1H-indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide hydrochloride |
925238-89-7 |
925238-89-7 |
| 4(1H)-Quinazolinone, 2,3-dihydro-2-[3-nitro-4-(1-piperidinyl)phenyl]- |
WAY-657206 |
852938-33-1 |
| Epoxy Metradiene |
氟米龙杂质 |
83873-16-9 |
| Quizartinib |
CHIGLITAZAR |
743438-45-1 |
| Acetamide, N-(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)-2,2,2-trifluoro- |
马来酸茚达特罗杂质18 |
601487-90-5 |
| benzofuran-7-carbonitrile |
BENZOFURAN-7-CARBONITRILE |
52951-09-4 |
| VH 101, phenol |
(2S,4R)-1-((S)-2-(1-氟环丙烷甲酰胺基)-3,3-二甲基丁酰基)-4-羟基-N-(2-羟基-4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺 |
2306193-99-5 |
| 3-(7-Fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
3-(7-氟-1-氧代异吲哚-2-基)哌啶-2,6-二酮 |
2287267-33-6 |
QQ
微信
